Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: A report of two patients

Tohoku Journal of Experimental Medicine

Volumn 234, Issue 1, 2014, Pages 51-56

  Izumi, Yasumori ^a   Miyashita, Taiichiro ^a   Migita, Kiyoshi ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

Lactation; Lupus nephritis; Pregnancy; Systemic lupus erythematosus; Tacrolimus

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; COMPLEMENT; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MIZORIBINE; PREDNISOLONE; RO ANTIBODY; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH; CASE REPORT; CESAREAN SECTION; COMPLEMENT BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG PULSE THERAPY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HUMAN; INFORMED CONSENT; KIDNEY BIOPSY; LACTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; NEWBORN CARE; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROTEINURIA; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; BLOOD; JAPAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHYSIOLOGY; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; LACTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDNISOLONE; PREGNANCY; PREGNANCY OUTCOME; TACROLIMUS; TREATMENT OUTCOME;

EID: 84919372261     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.234.51     Document Type: Article

References (22)

1. Alsuwaida, A. (2011) Successful management of systemic lupus erythematosus nephritis fare-up during pregnancy with tacro-limus. Mod. Rheumatol., 21, 73-75.
2. Armenti, V.T., Constantinescu, S., Moritz, M.J. & Davison, J.M. (2008) Pregnancy after transplantation. Transplant. Rev. (Orlando), 22, 223-240.
3. Armenti, V.T., Radomski, J.S., Moritz, M.J., Gaughan, W.J., McGrory, C.H. & Coscia, L.A. (2003) Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin.Transpl., 131-141.
4. Bar, J., Stahl, B., Hod, M., Wittenberg, C., Pardo, J. & Merlob, P. (2003) Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience. Am. J. Med. Genet. A, 116A, 31-36.
5. Christopher, V., Al-Chalabi, T., Richardson, P.D., Muiesan, P., Rela, M., Heaton, N.D., O’Grady, J.G. & Heneghan, M.A. (2006) Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl., 12, 1138-1143.
6. Clark, C.A., Spitzer, K.A. & Laskin, C.A. (2005) Decrease in pregnancy loss rates in patients with systemic lupus erythema-tosus over a 40-year period. J. Rheumatol., 32, 1709-1712.
7. Clowse, M.E. (2007) Lupus activity in pregnancy. Rheum. Dis. Clin. North Am., 33, 237-252.
8. D’Cruz, D.P., Khamashta, M.A. & Hughes, G.R. (2007) Systemic lupus erythematosus. Lancet, 369, 587-596.
9. French, A.E., Soldin, S.J., Soldin, O.P. & Koren, G. (2003) Milk transfer and neonatal safety of tacrolimus. Ann. Pharmaco-ther., 37, 815-818.
10. Gardiner, S.J. & Begg, E.J. (2006) Breastfeeding during tacro-limus therapy. Obstet. Gynecol., 107, 453-455.
11. Hornberger, L.K. & Al Rajaa, N. (2010) Spectrum of cardiac involvement in neonatal lupus. Scand. J. Immunol., 72, 189-197.
12. Ideguchi, H., Ohno, S., Uehara, T. & Ishigatsubo, Y. (2013) Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital. Clin. Rev. Allergy Immunol., 44, 57-64.
13. Imbasciati, E., Tincani, A., Gregorini, G., Doria, A., Moroni, G., Cabiddu, G. & Marcelli, D. (2009) Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol. Dial. Transplant., 24, 519-525.
14. Kainz, A., Harabacz, I., Cowlrick, I.S., Gadgil, S.D. & Hagiwara, D. (2000) Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation, 70, 1718-1721.
15. Levy, R.A., Vilela, V.S., Cataldo, M.J., Ramos, R.C., Duarte, J.L., Tura, B.R., Albuquerque, E.M. & Jesús, N.R. (2001) Hydroxy-chloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus, 10, 401-404.
16. Østensen, M., Khamashta, M., Lockshin, M., Parke, A., Brucato, A., Carp, H., Doria, A., Rai, R., Meroni, P., Cetin, I., Derksen, R., Branch, W., Motta, M., Gordon, C., Ruiz-Irastorza, G., et al. (2006) Anti-infammatory and immunosuppressive drugs and reproduction. Arthritis Res. Ther., 8, 209.
17. Østensen, M., Lockshin, M., Doria, A., Valesini, G., Meroni, P., Gordon, C., Brucato, A. & Tincani, A. (2008) Update on safety during pregnancy of biological agents and some immu-nosuppressive anti-rheumatic drugs. Rheumatology (Oxford), 47 Suppl 3, 28-31.
18. Petri, M. (1998) Pregnancy in SLE. Baillieres Clin. Rheumatol., 12, 449-476.
19. Ruiz-Irastorza, G. & Khamashta, M.A. (2004) Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus, 13, 679-682.
20. Stojan, G. & Baer, A.N. (2012) Flares of systemic lupus erythema-tosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert Rev. Clin. Immunol., 8, 439-453.
21. Szeto, C.C., Kwan, B.C., Lai, F.M., Tam, L.S., Li, E.K., Chow, K.M., Gang, W. & Li, P.K. (2008) Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis. Rheumatology (Oxford), 47, 1678-1681.
22. Wagner, S.J., Craici, I., Reed, D., Norby, S., Bailey, K., Wiste, H.J., Wood, C.M., Moder, K.G., Liang, K.P., Liang, K.V., Rose, C., Rozkos, T., Sitina, M., Grande, J.P. & Garovic, V.D. (2009) Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus, 18, 342-347.